Ithan D. Peltan

Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020

Mark W. Tenforde, Sara Kim, Christopher J. Lindsell et al. · MMWR Morbidity and Mortality Weekly Report · 2020 · 1.4K citations · Full text

Prolonged Symptom Duration, Population Health Sciences, Covid-19 Epidemiology +19

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity

Mark W. Tenforde, Wesley H. Self, Katherine Adams et al. · JAMA · 2021 · 671 citations · Full text

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

Adam S. Lauring, Mark W. Tenforde, James D. Chappell et al. · BMJ · 2022 · 666 citations · Full text

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

Wesley H. Self, Mark W. Tenforde, Jillian P. Rhoads et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 445 citations · Full text

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

Mark W. Tenforde, Samantha M. Olson, Wesley H. Self et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 319 citations · Full text